Amgen announced a $600 million investment to establish a state-of-the-art scientific research and development center at their global headquarters in Thousand Oaks, California. The facility aims to foster interdisciplinary collaboration, technological innovation, and accelerate the discovery of next-generation therapeutics for serious diseases. Construction is expected to commence in the third quarter of 2025 and will create hundreds of U.S. jobs. This project reflects Amgen's ongoing commitment to U.S.-based biotechnology innovation and advanced manufacturing capabilities.